Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34

Mice heterozygous for targeted disruption of Pthrp exhibit, by 3 months of age, diminished bone volume and skeletal microarchitectural changes indicative of advanced osteoporosis. Impaired bone formation arising from decreased BM precursor cell recruitment and increased apoptotic death of osteoblast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Miao, Dengshun, He, Bin, Jiang, Yebin, Kobayashi, Tatsuya, Sorocéanu, Maria A., Zhao, Jenny, Su, Hanyi, Tong, Xinkang, Amizuka, Norio, Gupta, Ajay, Genant, Harry K., Kronenberg, Henry M., Goltzman, David, Karaplis, Andrew C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2005
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1193882/
https://ncbi.nlm.nih.gov/pubmed/16138191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI24918
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados